4:07 PM
 | 
Jan 10, 2018
 |  BC Extra  |  Company News

Duchenne UK launches data-sharing initiative

The non-profit patient group Duchenne UK is collaborating with seven biotech and pharma companies and two universities to generate and share disease-level data to improve submissions for new treatments for Duchenne muscular dystrophy to Health Technical Assessment (HTA) regulatory bodies.

The organization launched Project Hercules with support from Pfizer Inc. (NYSE:PFE), PTC Therapeutics Inc. (NASDAQ:PTCT), Roche (SIX:ROG; OTCQX:RHHBY), Sarepta Therapeutics Inc. (NASDAQ:SRPT),...

Read the full 292 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >